Search by Drug Name or NDC

    NDC 55111-0396-13 Famotidine 20 mg/1 Details

    Famotidine 20 mg/1

    Famotidine is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Dr.Reddys Laboratories Limited. The primary component is FAMOTIDINE.

    Product Information

    NDC 55111-0396
    Product ID 55111-396_0e165efa-c6cc-c254-e143-a757293c26b3
    Associated GPIs 49200030000320
    GCN Sequence Number 011677
    GCN Sequence Number Description famotidine TABLET 20 MG ORAL
    HIC3 Z2D
    HIC3 Description HISTAMINE H2-RECEPTOR INHIBITORS
    GCN 46430
    HICL Sequence Number 004521
    HICL Sequence Number Description FAMOTIDINE
    Brand/Generic Generic
    Proprietary Name Famotidine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Famotidine
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name FAMOTIDINE
    Labeler Name Dr.Reddys Laboratories Limited
    Pharmaceutical Class Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077367
    Listing Certified Through 2024-12-31

    Package

    NDC 55111-0396-13 (55111039613)

    NDC Package Code 55111-396-13
    Billing NDC 55111039613
    Package 1 BOTTLE in 1 CARTON (55111-396-13) / 130 TABLET in 1 BOTTLE
    Marketing Start Date 2020-10-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 387088a6-8eaa-fc49-8050-a546d0f0fd32 Details

    Revised: 8/2021